You are invited to attend an FDA public workshop planned for March 29, 2019 titled Leveraging Human-Relevant Cardiomyocytes in Nonclinical Studies to Provide Mechanistic Insights into Cardiovascular Safety Liabilities. Registration required by March 27.
The Food and Drug Administration is announcing the following public workshop entitled "Regulatory Perspectives on Otic and Vestibular Toxicity: Challenges in Translating Animal Studies to Human Risk Assessment.”
Staff Fellow, In Vivo Research Position - U.S. FDA
Silver Spring, Maryland, USA
An update from our AAALAC Liaison, Nancy Poy, with some news from the United States Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) recent decision on third-party inspections
One of the benefits of SPS membership is the right to cast your vote on an annual basis to elect the Society’s leaders.